We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

1 hedge funds and large institutions have $76K invested in Dicerna Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $73K | Put options by funds: $20K

99% less funds holding

Funds holding: 1731 (-172)

100% less capital invested

Capital invested by funds: $1.25B → $76K (-$1.25B)

100% less funds holding in top 10

Funds holding in top 10: 50 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
170
Calls
$73K
Puts
$20K
Net Calls
+$53K
Net Calls Change
-$10.6M
Name Holding Trade Value Shares
Change
Change in
Stake
EMG
101
ETF Managers Group
New Jersey
-$563K -28,384 Closed
GIM
102
Granahan Investment Management
Massachusetts
-$560K -27,775 Closed
ProShare Advisors
103
ProShare Advisors
Maryland
-$514K -25,509 Closed
Edgewood Management
104
Edgewood Management
Connecticut
-$504K -25,000 Closed
MIM
105
MetLife Investment Management
New Jersey
-$501K -24,854 Closed
Jane Street
106
Jane Street
New York
-$491K -24,368 Closed
Sumitomo Mitsui Trust Group
107
Sumitomo Mitsui Trust Group
Japan
-$482K -23,901 Closed
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
-$477K -23,671 Closed
RJA
109
Raymond James & Associates
Florida
-$448K -22,207 Closed
ASN
110
Advisory Services Network
Georgia
-$410K -20,328 Closed
MLICM
111
Metropolitan Life Insurance Company (MetLife)
New York
-$408K -20,238 Closed
JG
112
Jefferies Group
New York
-$403K -20,004 Closed
TI
113
Trexquant Investment
Connecticut
-$389K -19,298 Closed
VWM
114
Vigilare Wealth Management
Arizona
-$387K -19,200 Closed
ASRS
115
Arizona State Retirement System
Arizona
-$380K -18,852 Closed
Handelsbanken Fonder
116
Handelsbanken Fonder
Sweden
-$363K -18,000 Closed
EGM
117
Engineers Gate Manager
New York
-$346K -17,178 Closed
XT
118
XTX Topco
Cayman Islands
-$343K -17,008 Closed
HT
119
HAP Trading
New York
-$330K -16,352 Closed
HW
120
Hancock Whitney
Mississippi
-$321K -15,908 Closed
SPC
121
Sigma Planning Corp
Michigan
-$283K -14,016 Closed
Public Employees Retirement Association of Colorado
122
Public Employees Retirement Association of Colorado
Colorado
-$278K -13,778 Closed
SEC
123
Seven Eight Capital
New York
-$266K -13,200 Closed
BNP Paribas Financial Markets
124
BNP Paribas Financial Markets
France
-$253K -12,542 Closed
AB
125
Amalgamated Bank
New York
-$250K -12,379 Closed

DRNA Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2021, worth a combined $76K — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of DRNA and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $153M sold.

  • 1 institutional investor held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2021, down from 173 in Q3 2021.
  • Funds reported $76K of Dicerna Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2021 and 170 closed out, a net change of -170 holders.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2021 was RTW Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q4 2021.